Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03501030
Other study ID # 29/18
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date November 25, 2019
Est. completion date October 1, 2021

Study information

Verified date August 2021
Source Federico II University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

to test the hypothesis that activity restriction in women with singleton gestations and with arrested PTL would reduce the rate of PTB.


Description:

Preterm birth (PTB) is a major cause of perinatal morbidity and mortality. Worldwide, about 15 million babies are born too soon every year, causing 1.1 million deaths, as well as short- and long-term disability in countless survivors. Preterm labor (PTL) is the final pathway for about 50% of all PTB. Tocolytic agents are drugs that can slow or stop labor contractions in the attempt to delay births preceded by PTL. Primary tocolysis is defined as tocolysis given on initial presentation of women with PTL. In most of these women, PTL stops, but as their risk of PTB remains high, some have advocated use of maintenance tocolysis, i.e. tocolysis after arrested PTL. So far, no maintenance tocolytic agent has been shown to be beneficial in preventing PTB. Some authors have also advocated the use of activity restriction in women with arrested PTL to reduce the risk of PTB. Activity restriction is defined as the following forms of activity restriction: pelvic rest and prohibition of sexual activity, reduction of work and/or non work activity. So far, the benefit of activity restriction in women with arrested PTL is still subject of debate and no Randomized Controlled Trial (RCT) has been undertaken. Thus, the aim of this trial is to test the hypothesis that activity restriction in women with singleton gestations and with arrested PTL would reduce the rate of PTB.


Recruitment information / eligibility

Status Recruiting
Enrollment 120
Est. completion date October 1, 2021
Est. primary completion date September 1, 2021
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria: - singleton gestations; - arrested PTL; - TVU CL < 25 mm; - 18 years to 50 years. Exclusion Criteria: - multiple gestations; - symptoms of PTL (not arrested PTL); - TVU CL = 25mm; - premature rupture of amnion and chorion membranes (PROM) at the time of randomization; - cerclage in situ at the time of randomization; - pessary in situ at the time of randomization; - vaginal bleeding at the time of randomization; - women who are unconscious, severly ill, mentally handicapped; - women under the age of 18 years or over the age of 50 years.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Activity restriction
Women in the intervention group will be recommended activity restriction. Activity restriction is defined as the following forms of activity restriction: pelvic rest and prohibition of sexual activity, reduction of work and/or non work activity. Bed rest will not recommended.

Locations

Country Name City State
Italy Giuseppe De Placido Napoli

Sponsors (1)

Lead Sponsor Collaborator
Federico II University

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary Preterm birth Preterm delivery at less than 37 weeks of gestation 37 weeks of gestation
Secondary Mean gestational age at delivery in weeks Mean gestational age at delivery in weeks At the time of delivery
Secondary Mean latency from randomization to delivery from randomization to delivery
Secondary admission to nicu number of babies admitted to neonatal intensive care unit at the time of delivery until 28 days of life
Secondary neonatal death death of a live-born baby at the time of delivery until 28 days of life
Secondary a composite of adverse perinatal outcome defined as at least one of the following:
necrotizing enterocolitis (NEC);
intraventricular hemorrhage (IVH) grade 3 or higher;
respiratory distress syndrome (RDS);
bronchopulmonry dysplasia (BPD);
retinopathy of prematurity (ROP) requiring therapy;
blood-culture proven sepsis;
admission to neonatal intensive care unit (NICU);
neonatal death;
at the time of delivery until 28 days of life
Secondary chorioamnionitis diagnosis of choriamnionitis at histological examination of the placenta. at the time of delivery
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05934318 - L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE) N/A
Completed NCT05502510 - Assessing the Effectiveness and Efficacy of the MyHealthyPregnancy Application
Not yet recruiting NCT03418012 - Prevention of sPTB With Early Cervical Pessary Treatment in Women at High Risk for PTB N/A
Not yet recruiting NCT03418311 - Cervical Pessary Treatment for Prevention of s PTB in Twin Pregnancies on Children`s Long-Term Outcome N/A
Completed NCT02993744 - Maternal Inflammatory Parameters Within Routine Treatment With Betamethasone N/A
Active, not recruiting NCT02673216 - Infection and Adverse Pregnancy Outcome
Completed NCT01683565 - Preemie Tots: A Pilot Study to Understand the Effects of Prematurity in Toddlerhood Phase 4
Completed NCT01460576 - Improving Prematurity-Related Respiratory Outcomes at Vanderbilt N/A
Completed NCT01412931 - Protein and Ultrasound Indicators of Preterm Birth N/A
Completed NCT02606058 - The Australian Placental Transfusion Study (APTS): Should Very Pre Term Babies Receive a Placental Blood Transfusion at Birth Via Deferring Cord Clamping Versus Standard Cord Clamping Procedures? N/A
Terminated NCT03715530 - Use of Placental Alpha Microglobulin-1(PAMG-1) to Diagnose Premature Rupture of Membranes in Pregnant Women N/A
Completed NCT00422526 - Progesterone for Prevention of Preterm Birth in Women With Short Cervix: Randomized Controlled Trial Phase 3
Enrolling by invitation NCT04251260 - Effectiveness of Positioning in Preterm Neonates N/A
Completed NCT03668860 - India Dexamethasone and Betamethasone Phase 1
Recruiting NCT03638037 - Correlation Between Maternal Vitamin D Level And Preterm Birth
Completed NCT02225353 - Efficacy Study of a Cervical Pessary Containing Progesterone for the Prevention of Preterm Delivery Phase 2
Recruiting NCT03992534 - The FLIP-1 Study: Vaginal Lactobacillus Supplementation in Women at High Risk of Preterm Birth Phase 1
Completed NCT03144141 - Association Between EHG and Risk of Preterm Delivery in Women Hospitalized for Threatened Premature Delivery N/A
Completed NCT05210985 - Examination of the Relationship Between Home Affordances With Development
Completed NCT04021654 - What is the Future of Vulnerable New-borns